EC 2.7.11.22 (cyclin-dependent kinase) inhibitor

Term ID

CHEBI:82665

Synonyms

ATP:cyclin phosphotransferase inhibitor
ATP:cyclin phosphotransferase inhibitors
Bur1 Cdk inhibitor
Bur1 Cdk inhibitors
Bur1 inhibitor
Bur1 inhibitors
Cak1 inhibitor
Cak1 inhibitors
Cak1p inhibitor
Cak1p inhibitors
cdc2 inhibitor
cdc2 inhibitors
cdc2 kinase inhibitor
cdc2 kinase inhibitors
Cdc28p inhibitor
Cdc28p inhibitors
CDK inhibitor
CDK inhibitors
cdk-activating kinase inhibitor
cdk-activating kinase inhibitors
Cdk-activating protein kinase inhibitors
Cdk1 inhibitor
Cdk1 inhibitors
Cdk19 inhibitor
Cdk19 inhibitors
Cdk2 inhibitor
Cdk2 inhibitors
Cdk3 inhibitor
Cdk3 inhibitors
Cdk4 inhibitor
Cdk4 inhibitors
Cdk5 inhibitor
Cdk5 inhibitors
Cdk6 inhibitor
Cdk6 inhibitors
Cdk7 inhibitor
Cdk7 inhibitors
Cdk8 inhibitor
Cdk8 inhibitors
Cdk9 inhibitor
Cdk9 inhibitors
cyclin A-activated cdc2 inhibitor
cyclin A-activated cdc2 inhibitors
cyclin A-activated cdk2 inhibitor
cyclin A-activated cdk2 inhibitors
cyclin D-cdk6 kinase inhibitor
cyclin D-cdk6 kinase inhibitors
cyclin D-dependent kinase inhibitor
cyclin D-dependent kinase inhibitors
cyclin E kinase inhibitor
cyclin E kinase inhibitors
cyclin-A associated kinase inhibitor
cyclin-A associated kinase inhibitors
cyclin-dependent kinase 6 inhibitor
cyclin-dependent kinase 6 inhibitors
cyclin-dependent kinase inhibitor
cyclin-dependent kinase inhibitors
cyclin-dependent kinase-2 inhibitor
cyclin-dependent kinase-2 inhibitors
cyclin-dependent kinase-4 inhibitor
cyclin-dependent kinase-4 inhibitors
cyclin-dependent protein kinase activating kinase inhibitor
cyclin-dependent protein kinase activating kinase inhibitors
cyk inhibitor
cyk inhibitors
D-type cyclin kinase inhibitor
D-type cyclin kinase inhibitors
EC 2.7.11.22 (cyclin-dependent kinase) inhibitors
EC 2.7.11.22 inhibitor
EC 2.7.11.22 inhibitors
ndk inhibitor
ndk inhibitors
neuronal cdc2-like kinase inhibitor
neuronal cdc2-like kinase inhibitors
PCTAIRE-1 inhibitor
PCTAIRE-1 inhibitors
STK25 inhibitor
STK25 inhibitors

(all 78)

Definition

An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of cyclin-dependent kinase (EC 2.7.11.22).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 2.7.11.* (protein-serine/threonine kinase) inhibitor

EC 2.7.11.* (protein-serine/threonine kinase) inhibitor Show first 5 Terms
inverse has_role: (R)-DRF053 (R)-DRF053 hydrochloride hydrate 2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide 4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide 4-(2,6-difluorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide ... Show All 39 Terms

(R)-DRF053 (R)-DRF053 hydrochloride hydrate 2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide 4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide 4-(2,6-difluorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide adapalene alsterpaullone alvocidib alvocidib hydrochloride AMG-925 asnuciclib bohemine CAN-508 CCT251545 CP681301 DH334 DH334(1+) dinaciclib enitociclib indirubin-3'-monoxime kenpaullone LDC4297 leucettine L41 N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-2-(4-methylpiperazin-1-yl)pyridine-4-carboxamide N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide olomoucine palbociclib paullone PHA-533533 riviciclib rohitukine ryuvidine seliciclib SGC-CLK-1 THZ1 THZ531 Show first 5 Terms

Phenotype

Phenotype resulting from EC 2.7.11.22 (cyclin-dependent kinase) inhibitor

Phenotype where environments contain EC 2.7.11.22 (cyclin-dependent kinase) inhibitor

Phenotype modified by environments containing EC 2.7.11.22 (cyclin-dependent kinase) inhibitor

Phenotype affecting EC 2.7.11.22 (cyclin-dependent kinase) inhibitor

Human Disease Model